Home / DSC127 / Journal Articles

The development of DSC127 (an Angiotensin II analog also referred to as NorLeu3-A(1-7)) has been featured in various peer-reviewed journals around the globe.
  • Histological evaluation of the effects of angiotensin peptides on wound repair in diabetic mice.
    Rodgers KE, Roda N, Felix JC, Espinoza T, Maldonado S, diZerega G. Experimental Dermatology 2003;12(6):784-790.
  • Development of angiotensin (1-7) as an agent to accelerate dermal repair.
    Rodgers K, Xiong S, Felix J, Roda N, Espinoza T, Maldonado S, diZerega G. Wound Repair Regen 2001;9:238-250.
  • Acceleration of healing, Reduction of fibrotic scar, and normalization of tissue architecture by an angiotensin analogue, norleu3-a(1-7).
    Rodgers KE, Espinoza T, Felix J, Roda N, Maldonado S, diZerega Plast Reconstr Surg 2003;111:1195-1206.
  • Acceleration of dermal tissue repair by Angiotensin II.
    Rodgers, KE, Abiko M, Girgis W, St. Amand KM, Campeau JD, diZerega GS. Wound Repair Regen 1997;5:175-183.
  • Histologic alterations in dermal repair after thermal injury: effects of topical angiotensin II.
    Rodgers, KE, DeCherney AH, St. Amand KM, Dougherty WR, Felix JC,, Girgis W, diZerega GS. Burn Care and Rehabilitation 1997;18:381-388.
  • Effect of angiotensin II on the viability, vascularity of random flaps in a rat model.
    Okuyama N, Roda N, Guerrero A, Dougherty W, Nguyen T, diZerega GS, Rodgers KE. Annals Plastic Surgery Res 1999;68:913-918.
  • Effect of NorLeu3-A(1-7) on scar formation over time after full thickness incision injury in the rat.
    Rodgers KE, Ellefson DD, Espinoza T, Roda N, Maldonado S, diZerega GS. Wound Repair Regen 2005;13:309-317.